GH - Guardant Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
39.81
-2.08 (-4.97%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close41.89
Open41.73
Bid39.50 x 1100
Ask41.80 x 1000
Day's Range38.02 - 41.85
52 Week Range27.04 - 49.55
Volume778,020
Avg. Volume800,512
Market Cap3.414B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Probable Reason Guardant Health Is Soaring Today
    Motley Fool13 days ago

    The Probable Reason Guardant Health Is Soaring Today

    This recent IPO is red hot, but what can explain today's jump?

  • Here's how much better insiders have profited from this year's IPO boom
    American City Business Journals20 days ago

    Here's how much better insiders have profited from this year's IPO boom

    If you bought one share at the IPO price of each of the Bay Area companies who went public this year, your portfolio would be up 37 percent on the year. But you would only have a 3 percent return if you bought all of those shares at their opening market price.

  • MarketWatch27 days ago

    Guardant Health reports first earnings since IPO

    Guardant Health Inc. reported earnings late Monday that missed Wall Street profit expectations but beat on sales. It was the company's first earnings since its initial public offering earlier this year. Guardant reported third-quarter net losses of $24.5 million, or $1.94 a share, compared with losses of $33.3 million, or $2.76 a share, in the year-ago period. Revenue rose to $21.7 million from $11.1 million in the year-ago period. The five analysts surveyed by FactSet had estimated losses of 29 cents a share on revenue of $17.4 million. For the fourth quarter, analysts model losses of 32 cents a share on sales of $21.2 million. Guardant said it expects full-year 2018 revenue of $82 million to $84 million; the FactSet consensus is for revenue of $74.4 million. Guardant stock closed down roughly 10% in Monday trading, with the S&P 500 index falling 1.7%.

  • Where SoftBank’s Vision Fund is deploying its $100 billion
    Yahoo Financelast month

    Where SoftBank’s Vision Fund is deploying its $100 billion

    SoftBank's Vision Fund portfolio includes a little of everything, from startups that send satellites to space, to one that helps humans walk dogs. Here's what it means for the market.

  • Strong IPO pace continued in October but some cracks are showing
    American City Business Journals2 months ago

    Strong IPO pace continued in October but some cracks are showing

    Nearly half of the 22 U.S. IPOs in October priced below their range, according to Renaissance Capital, which manages exchange-traded funds made up of IPO stocks. Several more were postponed.

  • Health Care Digest: A small biotech goes head first, Gilead's lower tax rate and more
    American City Business Journals2 months ago

    Health Care Digest: A small biotech goes head first, Gilead's lower tax rate and more

    Small VistaGen is building a portfolio of drugs aimed at depression and other mental health conditions, while giant Gilead gets a lower effective tax rate — all that and more in our Health Care Digest.

  • Unicorn births outpace IPOs in Bay Area: Here are the 24 new ones so far this year
    American City Business Journals2 months ago

    Unicorn births outpace IPOs in Bay Area: Here are the 24 new ones so far this year

    Only eight of the Bay Area's unicorns have gone public this year. Meanwhile, 24 new ones have been born. Here's a look at all of them.

  • Guardant Health IPO: 5 things to know about the startup that wants to detect cancer early
    MarketWatch2 months ago

    Guardant Health IPO: 5 things to know about the startup that wants to detect cancer early

    The startup’s cancer tests help match patients with the right treatments. It also has even bigger ambitions: to use its tests to find cancer recurrences, and even for early detection of cancers.

  • MarketWatch2 months ago

    Guardant Health's stock soars in public debut after IPO prices above expectations

    Shares of Guardant Health Inc. soared in their public debut Thursday, as they opened 46% above the initial public offering price, which was well above the expected range. The first trade for the cancer detection and treatment company's stock was at $27.75 at 10:48 a.m. ET for 1.7 million shares. That compares with the IPO price of $19, which was above the expected range of $15 to $17. The stock has extended gains since then, to trade up 51%. The company raised $237.5 million with the IPO, which values the company at $1.6 billion. Guardant is going public at a time that the Renaissance IPO ETF has slipped 0.9% over the past three months, while the iShares Nasdaq Biotechnology ETF has gained 7.5% and the S&P 500 has advanced 7.1%.

  • MarketWatch2 months ago

    Guardant Health IPO prices above expected range to value company at $1.6 billion

    Guardant Health Inc. said Thursday its initial public offering of 12.5 million shares priced at $19 a share, above the expected range of $15 to $17 a share, to raise $237.5 million. If the underwriters exercise all the options granted to buy additional shares, oncology company could raise up to $273.1 million. The IPO pricing values the Redwood City, Calif.-based company at $1.59 billion. The company had a net loss of $83.2 million on revenue of $49.8 million in 2017, compared with a loss of $46.1 million and revenue of $25.2 million in 2016. The stock is expected to begin trading Thursday on the Nasdaq under the ticker symbol "GH." The company is going public at a time that the Renaissance IPO ETF has gained 5.0% year to date and the S&P 500 has gained 9.4%.

  • Benzinga3 months ago

    IPO Outlook For The Week: Diagnostics, Data Miners And Freelance Facilitators

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . Upwork Inc. (UPWK) will issue nearly 12.3 million shares between $10 and $12 Wednesday on the Nasdaq. Upwork’s online platform ...